Draft Genome Sequence of Triclosan-Resistant Cystic Fibrosis Isolate Achromobacter xylosoxidans CF304.

Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 101595808 Publication Model: Electronic Cited Medium: Print ISSN: 2169-8287 (Print) NLM ISO Abbreviation: Genome Announc Subsets: PubMed not MEDLINE

Original Publication: Washington, DC : American Society for Microbiology

Achromobacter xylosoxidans is an emerging opportunistic pathogen. Here, we present the genome sequence of cystic fibrosis isolate CF304. Assembly resulted in 29 contigs adding up to 6.3 Mbp. This is the second genome sequence for a cystic fibrosis isolate, and little is known about the genetic basis of pathogenicity in this organism.
(Copyright © 2015 Jeukens et al.)

Bioinformatics. 2015 Nov 15;31(22):3691-3. (PMID: 26198102)
J Comput Biol. 2000 Feb-Apr;7(1-2):203-14. (PMID: 10890397)
Eur J Clin Microbiol Infect Dis. 2011 Aug;30(8):973-80. (PMID: 21279730)
PLoS One. 2013 Jul 22;8(7):e68484. (PMID: 23894309)
Front Microbiol. 2014 Apr 03;5:138. (PMID: 24772108)
BMC Res Notes. 2012 Jan 19;5:43. (PMID: 22260715)
Front Microbiol. 2015 Jan 15;5:780. (PMID: 25642217)
Antimicrob Agents Chemother. 2010 Feb;54(2):689-98. (PMID: 19933806)
Semin Respir Crit Care Med. 2007 Jun;28(3):312-21. (PMID: 17562501)
J Cyst Fibros. 2010 Jan;9(1):51-8. (PMID: 19939747)
Genome Biol. 2014;15(11):524. (PMID: 25410596)
PLoS One. 2012;7(9):e42304. (PMID: 23028432)

Date Created: 20150801 Date Completed: 20150803 Latest Revision: 20200929

20231215

PMC4520907

10.1128/genomeA.00865-15

26227609